Early sorafenib‐related adverse events predict therapy response of TACE plus sorafenib: A multicenter clinical study of 606 HCC patients
暂无分享，去创建一个
R. Duran | D. Fan | Zhuoli Zhang | G. Han | W. Mu | Hailiang Li | W. Bai | Xiaochen Qin | Z. Yin | S. Gu | Yan Zhao | Wengang Guo | Weifu Lv | Wenjun Wang | W. Ren | Yi-Long Ma | Yongji Wang | Wenhui Wang | Jueshi Liu | S. Guan | Sonia Sahu | W. Guo